These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15308017)

  • 1. [Effect of the tetra-arsenic tetra-sulfide (As4S4) on the corrected QT interval in the treatment of acute promyelocytic leukemia].
    Shen JC; Liu KY; Jiang B; Lu XJ; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jun; 25(6):359-61. PubMed ID: 15308017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of arsenic trioxide on QT interval prolongation during APL therapy.
    Zhou J; Meng R; Li X; Lu C; Fan S; Yang B
    Chin Med J (Engl); 2003 Nov; 116(11):1764-6. PubMed ID: 14642155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of tetra-arsenic tetra-sulfide in inducing apoptosis of acute promyelocytic leukemia cells].
    Teng ZP; Zhang P; Zhu HH; Hao HY; Qin XY; Hao L; Xu H; Lu DP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):236-8. PubMed ID: 16778962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.
    Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Jiang H; Chen SJ; Huang XJ
    J Clin Oncol; 2013 Nov; 31(33):4215-21. PubMed ID: 24127444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of arsenic trioxide on QT interval in patients with advanced malignancies.
    Barbey JT; Pezzullo JC; Soignet SL
    J Clin Oncol; 2003 Oct; 21(19):3609-15. PubMed ID: 14512391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetra-arsenic tetra-sulfide (As4S 4) promotes apoptosis in retinoid acid -resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.
    Liu Y; He P; Liu F; Zhou N; Cheng X; Shi L; Zhu H; Zhao J; Wang Y; Zhang M
    Tumour Biol; 2014 Apr; 35(4):3421-30. PubMed ID: 24430359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetics and Safety of Oral Tetra-Arsenic Tetra-Sulfide Formula in Pediatric Acute Promyelocytic Leukemia.
    Zhang L; Yang XM; Chen J; Hu L; Yang F; Zhou Y; Zhao BB; Zhao W; Zhu XF
    Drug Des Devel Ther; 2021; 15():1633-1640. PubMed ID: 33911851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetra-arsenic tetra-sulfide enhances NK-92MI mediated cellular immunotherapy in all-trans retinoic acid-resistant acute promyelocytic leukemia.
    Liu Y; Jia Y; Liu Y; Chen X; Zhang M
    Invest New Drugs; 2022 Dec; 40(6):1231-1243. PubMed ID: 36287298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic sulfide promotes apoptosis in retinoid acid resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.
    Tian Y; Liu Y; He P; Liu F; Zhou N; Cheng X; Shi L; Zhu H; Zhao J; Wang Y; Zhang M
    PLoS One; 2014; 9(1):e83184. PubMed ID: 24454695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prohibitin promotes apoptosis of promyelocytic leukemia induced by arsenic sulfide.
    He P; Liu Y; Qi J; Zhu H; Wang Y; Zhao J; Cheng X; Wang C; Zhang M
    Int J Oncol; 2015 Dec; 47(6):2286-95. PubMed ID: 26498315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of all-trans retinoic acid combining chemotherapy and As4S4 in the maintenance treatment of patients with acute promyelocytic leukemia].
    Lin QD; Wei XD; Wang P; Liu YY; Zhang LN; Li YF; Gao QL; Zhu XH; Zhang YL; Fang BJ; Yue H; Du JW; Jiang DX; Hu JY; Song YP
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):19-21. PubMed ID: 17649720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report.
    Lu DP; Qiu JY; Jiang B; Wang Q; Liu KY; Liu YR; Chen SS
    Blood; 2002 May; 99(9):3136-43. PubMed ID: 11964275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmogenic effects of arsenic trioxide in patients with acute promyelocytic leukemia and an electrophysiological study in isolated guinea pig papillary muscles.
    Yamazaki K; Terada H; Satoh H; Naito K; Takeshita A; Uehara A; Katoh H; Ohnishi K; Hayashi H
    Circ J; 2006 Nov; 70(11):1407-14. PubMed ID: 17062962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic hepatic damage in acute promyelocytic leukemia patients treated with tetra-arsenic tetra-sulfide].
    Qin XY; Jiang B; Li GX; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):259-63. PubMed ID: 16875560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraarsenictetrasulfide and Arsenic Trioxide Exert Synergistic Effects on Induction of Apoptosis and Differentiation in Acute Promyelocytic Leukemia Cells.
    Wang S; Zhou M; Ouyang J; Geng Z; Wang Z
    PLoS One; 2015; 10(6):e0130343. PubMed ID: 26110921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical pharmacokinetic study of multi-dose oral tetra-arsenic tetra-sulfide combination therapy in acute promyelocytic leukemia].
    Wang FR; Lou YQ; Lu DP
    Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):730-3. PubMed ID: 16255875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular repolarization dynamics in arsenic trioxide treatment of acute promyelocytic leukemia.
    Sun Y; Wang L; Que Y; Zhu H; Yang X; Li D
    Int J Cardiol; 2020 May; 306():163-167. PubMed ID: 31761398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tetra-arsenic tetra-sulfide on BXSB lupus-prone mice: a pilot study.
    Zhao Y; Wen G; Qiao Z; Xu H; Sun Q; Huang H; Shan S; Mu Z; Zhang J
    Lupus; 2013 Apr; 22(5):469-76. PubMed ID: 23554035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, management, and clinical consequences of QT interval prolongation during treatment with arsenic trioxide.
    Roboz GJ; Ritchie EK; Carlin RF; Samuel M; Gale L; Provenzano-Gober JL; Curcio TJ; Feldman EJ; Kligfield PD
    J Clin Oncol; 2014 Nov; 32(33):3723-8. PubMed ID: 25245447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. As
    Wu D; Dong W; Fang K; Wang M
    Technol Cancer Res Treat; 2019; 18():1533033819896806. PubMed ID: 31868118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.